Trials / Unknown
UnknownNCT05145894
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Healthy Networks · Industry
- Sex
- All
- Age
- 3 Years
- Healthy volunteers
- Not accepted
Summary
This observational study evaluates whether lung sound analysis with LungPass device can be used to differentiate exacerbation and stable state asthma and COPD.
Detailed description
This is a prospective observational study comprised patients with moderate or severe COPD or asthma exacerbation in primary care settings. Patients will be examined twice - during an exacerbation of the disease and in a stable phase. Patients will undergo routine clinical examination including lung auscultation with conventional stethoscope and LungPass device. Moreover, symptoms and anamnesis data, results of symptoms questionnaires (CAT for COPD and ACQ-5 for asthma), result of diagnostic questionnaire from the LungPass App, spirometry data, serum procalcitonin (for COPD patients), C-reactive protein, white blood cell count and blood eosinophil count, results of sputum cytology examination, Х-ray results (if carried out according to indications) will be collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lung auscultation with LungPass device (electronic auscultation) | Lung auscultation with electronic stethoscope |
Timeline
- Start date
- 2021-09-30
- Primary completion
- 2022-09-30
- Completion
- 2022-09-30
- First posted
- 2021-12-06
- Last updated
- 2021-12-06
Locations
1 site across 1 country: Belarus
Source: ClinicalTrials.gov record NCT05145894. Inclusion in this directory is not an endorsement.